These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17329109)

  • 1. Modeling of human ghrelin receptor (hGHS-R1a) in its close state and validation by molecular docking.
    Pedretti A; Vistoli G
    Bioorg Med Chem; 2007 Apr; 15(8):3054-64. PubMed ID: 17329109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis.
    Pedretti A; Villa M; Pallavicini M; Valoti E; Vistoli G
    J Med Chem; 2006 Jun; 49(11):3077-85. PubMed ID: 16722627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling of full-length human alpha4beta2 nicotinic receptor by fragmental approach and analysis of its binding modes.
    Pedretti A; Marconi C; Bolchi C; Fumagalli L; Ferrara R; Pallavicini M; Valoti E; Vistoli G
    Biochem Biophys Res Commun; 2008 May; 369(2):648-53. PubMed ID: 18302933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
    Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragmental modeling of human glutamate transporter EAAT1 and analysis of its binding modes by docking and pharmacophore mapping.
    Pedretti A; De Luca L; Sciarrillo C; Vistoli G
    ChemMedChem; 2008 Jan; 3(1):79-90. PubMed ID: 17990250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model.
    Kneissl B; Leonhardt B; Hildebrandt A; Tautermann CS
    J Med Chem; 2009 May; 52(10):3166-73. PubMed ID: 19397376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
    Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
    ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.
    Weill N; Rognan D
    J Chem Inf Model; 2009 Apr; 49(4):1049-62. PubMed ID: 19301874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approach.
    Kimura SR; Tebben AJ; Langley DR
    Proteins; 2008 Jun; 71(4):1919-29. PubMed ID: 18175323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
    Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding ligands for G protein-coupled receptors based on the protein-compound affinity matrix.
    Fukunishi Y; Kubota S; Nakamura H
    J Mol Graph Model; 2007 Jan; 25(5):633-43. PubMed ID: 16777448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
    Miller LJ; Dong M; Harikumar KG; Gao F
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.